Lees Screen in Concomitant Strabismus
Launched by MINIA UNIVERSITY · Dec 24, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a test called the Lees screen, which helps doctors see if there are any limitations in the eye movements of patients who have undergone surgery for strabismus. Strabismus is a condition where the eyes don’t align properly, which can lead to double vision or other visual problems. The trial is specifically looking at patients who have either esotropia (where one or both eyes turn inward) or exotropia (where one or both eyes turn outward). To participate, you need to be over 10 years old and have one of these conditions. However, if you’ve had previous eye surgery for strabismus or have certain other eye problems, you won’t be eligible for this study.
If you choose to participate in this trial, you will undergo the Lees screen test both before and after your strabismus surgery. This will help doctors understand how well the surgery is working in terms of eye movement and vision. The trial is currently recruiting participants, and it’s open to people of all genders. Your involvement can contribute to better understanding and treatment of strabismus, potentially helping others with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Concomitant esotropia
- • Concomitant exotropia
- • Above 10 years old patients
- Exclusion Criteria:
- • Restrictive and paralytic strabismus
- • Previous strabismus surgery
- • Mental disability
About Minia University
Minia University is a prestigious educational institution located in Egypt, dedicated to advancing medical research and clinical trials. With a commitment to fostering innovation and improving healthcare outcomes, the university collaborates with a diverse range of stakeholders, including healthcare professionals and researchers. Minia University aims to enhance clinical practices through rigorous research methodologies and ethical standards, contributing to the body of knowledge in the medical field while addressing local and global health challenges. The university's clinical trial initiatives are designed to evaluate new treatments and interventions, ensuring a positive impact on patient care and community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minya, Minia, Egypt
Patients applied
Trial Officials
Sahar TA Abdelaziz, MD
Principal Investigator
Minia University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials